These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17923855)

  • 1. Genetic changes in pT2 and pT3 prostate cancer detected by comparative genomic hybridization.
    Fukasawa S; Kino M; Kobayashi M; Suzuki H; Komiya A; Imamoto T; Hirokawa Y; Shiraishi T; Takiguchi M; Ishida H; Shindo T; Seki N; Ichikawa T
    Prostate Cancer Prostatic Dis; 2008; 11(3):303-10. PubMed ID: 17923855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
    Kobayashi M; Ishida H; Shindo T; Niwa S; Kino M; Kawamura K; Kamiya N; Imamoto T; Suzuki H; Hirokawa Y; Shiraishi T; Tanizawa T; Nakatani Y; Ichikawa T
    Prostate; 2008 Dec; 68(16):1715-24. PubMed ID: 18781578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer.
    Chu LW; Troncoso P; Johnston DA; Liang JC
    Genes Chromosomes Cancer; 2003 Mar; 36(3):303-12. PubMed ID: 12557230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.
    Postma R; van Marion R; van Duin M; Vissers KJ; Wink JC; Schröder FH; Tanke HJ; Szuhai K; van der Kwast TH; van Dekken H
    Anticancer Res; 2006; 26(2A):1193-200. PubMed ID: 16619524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic changes in localized prostate cancer of Japanese patients shown by comparative genomic hybridization.
    Kasahara K; Taguchi T; Yamasaki I; Kamada M; Shuin T
    Cancer Genet Cytogenet; 2005 May; 159(1):84-8. PubMed ID: 15860364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making.
    Teixeira MR; Ribeiro FR; Eknaes M; Waehre H; Stenwig AE; Giercksky KE; Heim S; Lothe RA
    Cancer; 2004 Oct; 101(8):1786-93. PubMed ID: 15386312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer.
    Matsuyama H; Pan Y; Oba K; Yoshihiro S; Matsuda K; Hägarth L; Kudren D; Naito K; Bergerheim US; Ekman P
    Clin Cancer Res; 2001 Oct; 7(10):3139-43. PubMed ID: 11595707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal aberrations detected by comparative genomic hybridization predict outcome in patients with colorectal carcinoma.
    Liu XP; Kawauchi S; Oga A; Sato T; Ikemoto K; Ikeda E; Sasaki K
    Oncol Rep; 2007 Jan; 17(1):261-7. PubMed ID: 17143507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
    Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
    Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
    Gburek BM; Kollmorgen TA; Qian J; D'Souza-Gburek SM; Lieber MM; Jenkins RB
    J Urol; 1997 Jan; 157(1):223-7. PubMed ID: 8976257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer.
    Matsuyama H; Pan Y; Oba K; Yoshihiro S; Matsuda K; Hägarth L; Kudren D; Naito K; Bergerheim US; Ekman P
    Aktuelle Urol; 2003 Jul; 34(4):247-9. PubMed ID: 14566675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
    van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
    Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma.
    Schulz WA; Elo JP; Florl AR; Pennanen S; Santourlidis S; Engers R; Buchardt M; Seifert HH; Visakorpi T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):58-65. PubMed ID: 12203790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer.
    Matsuyama H; Pan Y; Yoshihiro S; Kudren D; Naito K; Bergerheim US; Ekman P
    Prostate; 2003 Feb; 54(2):103-11. PubMed ID: 12497583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
    Laitinen S; Karhu R; Sawyers CL; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):66-73. PubMed ID: 12203791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?].
    Bubendorf L
    Verh Dtsch Ges Pathol; 2004; 88():158-64. PubMed ID: 16892547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.
    Saramäki O; Willi N; Bratt O; Gasser TC; Koivisto P; Nupponen NN; Bubendorf L; Visakorpi T
    Am J Pathol; 2001 Dec; 159(6):2089-94. PubMed ID: 11733359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
    Watson SK; Woolcock BW; Fee JN; Bainbridge TC; Webber D; Kinahan TJ; Lam WL; Vielkind JR
    Prostate; 2009 Jun; 69(9):961-75. PubMed ID: 19267368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.